Basic: Searching a New Molecular Targets
نویسندگان
چکیده
منابع مشابه
New directions in neuroprotection: basic mechanisms, molecular targets and treatment strategies.
Few diseases are as devastating as the neurodegenerative ones including: Alzheimer’s disease (AD), Parkinson’s disease (PD) and Amyotrophic Lateral Sclerosis (ALS), to name a few. Genetic risk-factors influence these age-associated, chronic illness but, by and large, the causes of these diseases remain unknown. There are known familial forms of AD, ALS and PD and the identification of mutations...
متن کاملSome New Properties of the Searching Probability
Consider search designs for searching one nonzero 2- or 3-factor interaction under the search linear model. In the noisy case, search probability is given by Shirakura et al. (Ann. Statist. 24(6) (1996) 2560). In this paper some new properties of the searching probability are presented. New properties of the search probability enable us to compare designs, which depend on an unknown parameter ?...
متن کاملNew Molecular Targets in Metastatic Prostate Cancer
Prostate cancer (PCa) is the second leading cause of cancer death in men. Despite initial responses, almost all patients progress to castration-resistant prostate cancer (CRPC). Over the past decade, increased understanding of the mechanisms that drive resistance to castration has led to the development of next-generation androgen receptor targeting agents such as abiraterone acetate and enzalu...
متن کاملNew Molecular Targets in Lung Adenocarcinoma
© Touch MEdical MEdia 2013 Abstract lung cancer is designated as either non-small-cell lung cancer (NSclc) or small-cell lung cancer. There are three subtypes of NSclc: adenocarcinoma (48 %), squamous cell carcinoma (28 %), and large-cell carcinoma (24 %). Epidermal growth factor receptor (EGFR) mutations, anaplastic lymphoma kinase (ALK) rearrangements, and ROS1 rearrangements are co-associate...
متن کاملNew molecular targets against cervical cancer
Cervical cancer is the third most commonly diagnosed cancer worldwide and the fourth leading cause of cancer death in women. Major advances but still insufficient achievements in the treatment of locally advanced and high-risk early stage patients have occurred in the last decade with the incorporation of concurrent cisplatin with radiation and, lately, gemcitabine added to cisplatin chemoradia...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2012
ISSN: 0923-7534
DOI: 10.1016/s0923-7534(20)32107-4